Filing Details
- Accession Number:
- 0001209191-18-015994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-02 18:40:34
- Reporting Period:
- 2018-02-28
- Accepted Time:
- 2018-03-02 18:40:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180262 | Herbalife Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1343530 | John Tartol | 800 W. Olympic Blvd. Suite 406 Los Angeles CA 90015 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-28 | 5,452 | $53.29 | 200,539 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-28 | 3,155 | $92.10 | 197,384 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2018-03-02 | 2,297 | $92.10 | 195,087 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2018-02-28 | 5,452 | $0.00 | 5,452 | $53.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-05-18 | 2021-05-18 | No | 4 | M | Direct |
Footnotes
- The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10.
Billionaire Hedge Funds
